Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
M-Strong CS is a multi-ingredient nutritional supplement developed and marketed by Lloyd Healthcare. It is formulated as a capsule containing a combination of Calcitriol (active Vitamin D3), Calcium Carbonate, Folic Acid (Vitamin B9), Mecobalamin (Methylcobalamin/Vitamin B12), and Pyridoxine (Vitamin B6). While categorized within Lloyd Healthcare's cardio-diabetic portfolio, it functions primarily as a vitamin and mineral supplement to support bone health, nerve function, and address nutritional deficiencies often associated with chronic conditions like diabetes or cardiovascular disease. Calcitriol and calcium support bone mineralization, while the B-vitamins (B6, B9, B12) are essential for homocysteine metabolism and neurological health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on M-Strong CS.